Financhill
Buy
54

TRVI Quote, Financials, Valuation and Earnings

Last price:
$4.25
Seasonality move :
52.76%
Day range:
$4.00 - $4.25
52-week range:
$1.27 - $4.68
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
5.49x
Volume:
543.2K
Avg. volume:
3M
1-year change:
194.41%
Market cap:
$323.6M
Revenue:
--
EPS (TTM):
-$0.44

Earnings Data

Next earnings date for TRVI
Mar 20
2025
Most recent earnings per share
-$0.13
Missed by $0.02
(Nov 6/2024)
Consensus Estimate
-$0.11
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TRVI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/20/2025 Q4 -- -- -- -$0.12 --
11/06/2024 Q3 -- -- -$0.13 -$0.11 -$0.02
08/08/2024 Q2 -- -- -$0.12 -$0.11 -$0.01
05/07/2024 Q1 -- -- -$0.11 -$0.09 -$0.02
03/20/2024 Q4 -- -- -$0.08 -$0.09 $0.01
11/09/2023 Q3 -- -- -$0.08 -$0.09 $0.01
08/10/2023 Q2 -- -- -$0.07 -$0.09 $0.02
05/11/2023 Q1 -- -- -$0.06 -$0.07 $0.01
03/16/2023 Q4 -- -- -$0.06 -$0.10 $0.04
11/10/2022 Q3 -- -- -$0.12 -$0.13 $0.01
08/11/2022 Q2 -- -- -$0.14 -$0.19 $0.05
05/12/2022 Q1 -- -- -$0.24 -$0.29 $0.05
03/17/2022 Q4 -- -- -$0.24 -$0.30 $0.06
11/10/2021 Q3 -- -- -$0.34 -$0.40 $0.06
08/12/2021 Q2 -- -- -$0.49 -$0.46 -$0.03
05/13/2021 Q1 -- -- -$0.43 -$0.52 $0.09
03/25/2021 Q4 -- -- -$0.51 -$0.44 -$0.07
11/11/2020 Q3 -- -- -$0.41 -$0.51 $0.10
08/12/2020 Q2 -- -- -$0.41 -$0.48 $0.07
05/07/2020 Q1 -- -- -$0.48 -$0.44 -$0.04
03/16/2020 Q4 -- -- -$0.37 -$0.51 $0.15
11/14/2019 Q3 -- -- -$0.41 -$0.48 $0.07
08/12/2019 Q2 -- -- -$0.41 -$0.42 $0.01
06/13/2019 Q1 -- -- -- -$0.52 --

Trevi Therapeutics Earnings Questions

  • How Much did Trevi Therapeutics Generate in Revenue Last Quarter?

    Trevi Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Trevi Therapeutics Beat Earnings Last Quarter?

    Trevi Therapeutics announced earnings per share of -$0.13 which represents a miss of analyst forecast a -$0.11 per share.

  • Is Trevi Therapeutics Profitable?

    Trevi Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Trevi Therapeutics EPS Next Year?

    Trevi Therapeutics's earnings are forecast to decrease from -$0.29 per share to -$0.30 per share next year representing a decrease of -68.97%.

  • When is Trevi Therapeutics's Earnings Date?

    Trevi Therapeutics's next earnings date is March 20, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is AMD Stock an All-Time Buy?
Is AMD Stock an All-Time Buy?

Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…

How High Will Airbnb Stock Go?
How High Will Airbnb Stock Go?

Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…

Why Is SoundHound AI Stock Up So Much?
Why Is SoundHound AI Stock Up So Much?

Like many companies improving AI technologies and exploring ways to…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 43x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
57
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Alerts

Buy
64
ARQQ alert for Dec 27

Arqit Quantum [ARQQ] is down 7.51% over the past day.

Buy
64
QMCO alert for Dec 27

Quantum [QMCO] is up 3.99% over the past day.

Buy
65
ALGS alert for Dec 27

Aligos Therapeutics [ALGS] is down 5.03% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock